Literature DB >> 25926282

An Efficient, Noniterative Method of Identifying the Cost-Effectiveness Frontier.

Sze-chuan Suen1, Jeremy D Goldhaber-Fiebert2.   

Abstract

Cost-effectiveness analysis aims to identify treatments and policies that maximize benefits subject to resource constraints. However, the conventional process of identifying the efficient frontier (i.e., the set of potentially cost-effective options) can be algorithmically inefficient, especially when considering a policy problem with many alternative options or when performing an extensive suite of sensitivity analyses for which the efficient frontier must be found for each. Here, we describe an alternative one-pass algorithm that is conceptually simple, easier to implement, and potentially faster for situations that challenge the conventional approach. Our algorithm accomplishes this by exploiting the relationship between the net monetary benefit and the cost-effectiveness plane. To facilitate further evaluation and use of this approach, we also provide scripts in R and Matlab that implement our method and can be used to identify efficient frontiers for any decision problem.
© The Author(s) 2015.

Entities:  

Keywords:  cost-effectiveness analysis frontier; net monetary benefit

Mesh:

Year:  2015        PMID: 25926282      PMCID: PMC4626430          DOI: 10.1177/0272989X15583496

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  2 in total

1.  Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI).

Authors:  Garry R Barton; Andrew H Briggs; Elisabeth A L Fenwick
Journal:  Value Health       Date:  2008-05-16       Impact factor: 5.725

2.  Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.

Authors:  Jeremy D Goldhaber-Fiebert; Natasha K Stout; Joshua A Salomon; Karen M Kuntz; Sue J Goldie
Journal:  J Natl Cancer Inst       Date:  2008-02-26       Impact factor: 13.506

  2 in total
  4 in total

Review 1.  Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.

Authors:  Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

2.  Optimal timing of drug sensitivity testing for patients on first-line tuberculosis treatment.

Authors:  Sze-Chuan Suen; Margaret L Brandeau; Jeremy D Goldhaber-Fiebert
Journal:  Health Care Manag Sci       Date:  2017-08-31

3.  Defining a Willingness-to-transplant Threshold in an Era of Organ Scarcity: Simultaneous Liver-kidney Transplant as a Case Example.

Authors:  Xingxing S Cheng; Jeremy Goldhaber-Fiebert; Jane C Tan; Glenn M Chertow; W Ray Kim; Anji E Wall
Journal:  Transplantation       Date:  2020-02       Impact factor: 5.385

4.  Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.

Authors:  Eugene Lin; Glenn M Chertow; Brandon Yan; Elizabeth Malcolm; Jeremy D Goldhaber-Fiebert
Journal:  PLoS Med       Date:  2018-03-27       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.